Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Profile Treatment Approach Name | PD-L1/PD-1 antibody |
Profile Name | MLH1 negative |
Drug Class | PD-L1/PD-1 antibody 122 |
Therapy |
PubMed Id | Reference Title | Details |
---|---|---|
(28734759) | Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. | Full reference... |
(33001143) | Clinical Activity and Safety of the Anti-Programmed Death 1 Monoclonal Antibody Dostarlimab for Patients With Recurrent or Advanced Mismatch Repair-Deficient Endometrial Cancer: A Nonrandomized Phase 1 Clinical Trial. | Full reference... |
(30787022) | FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors. | Full reference... |
(27412392) | Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade. | Full reference... |